Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prokidney (PROK) EPS (Weighted Average and Diluted) (2022 - 2025)

Prokidney (PROK) has disclosed EPS (Weighted Average and Diluted) for 4 consecutive years, with -$0.12 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 14.29% to -$0.12 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.55, a 1.79% increase, with the full-year FY2024 number at -$0.62, down 8.77% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.12 for Q3 2025 at Prokidney, up from -$0.13 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.07 in Q2 2022 to a low of -$0.23 in Q4 2022.
  • A 4-year average of -$0.14 and a median of -$0.14 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 56.52% in 2023; the steepest drop was 85.71% in 2023.
  • Prokidney's EPS (Weighted Average and Diluted) stood at -$0.23 in 2022, then soared by 56.52% to -$0.1 in 2023, then tumbled by 70.0% to -$0.17 in 2024, then rose by 29.41% to -$0.12 in 2025.
  • Per Business Quant, the three most recent readings for PROK's EPS (Weighted Average and Diluted) are -$0.12 (Q3 2025), -$0.13 (Q2 2025), and -$0.13 (Q1 2025).